Skip to main content

Congenital toxoplasmosis: past, present and future

  • Conference paper
Congenital toxoplasmosis

Abstract

Toxoplasmosis is the first infection of the TORCH complex (Toxoplasmosis, Rubella, Cytomegalovirus and Herpes simplex) and one of the most important congenital diseases. Consideration is too often limited to the cases of very severe toxoplasmosis with numerous and spectacular symptoms at birth, such as hydrocephalus, neurological disorders and ocular involvement, which lead to major handicaps. However, the frequency of attenuated, asymptomatic or poorly symptomatic congenital toxoplasmosis is often disregarded. The asymptomatic infections may give rise to very late reactivation, which sometimes occurs in puberty or even adulthood. The reactivation of unrecognised congenital toxoplasmosis is sometimes accompanied with neurological disorders, and is a common cause of retinochoroiditis. The retinochoroiditis can be very disabling and the majority cases of retinochoroiditis in young adults are thought to be secondary to untreated congenital toxoplasmosis. This is the most severe medical and socio-economical consequence of congenital toxoplasmosis and is the reason behind the pre- and neonatal screening programmes.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. Petersen E, Ambroise-Thomas P, Foulon W et al (1994) Congenital toxoplasmosis. The European Research Network on Congenital Toxoplasmosis. A concerted action under the EU research programm Biomed. J Obst Gynecol 14 (Suppl 2):112–117

    Google Scholar 

  2. Frenkel JK (1990) Diagnosis, incidence and prevention of congenital toxoplasmosis. Am J Dis Child 144:956–958

    PubMed  CAS  Google Scholar 

  3. Newton LH, Hall SM (1995) A survey of health education material for the primary prevention of congenital toxoplasmosis. Commun Dis Rep CDR Rev 5:R21–R27

    PubMed  CAS  Google Scholar 

  4. Ambroise-Thomas P, Pelloux H (1993) Toxoplasmosis congenital and in immun-compromised patients. A parallel. Parasitol Today 9:61–63

    Article  CAS  Google Scholar 

  5. Cristina N, Darde ML, Boudin C et al (1995) A DNA finger-printing method for individual characterization of Toxoplasma gondii strains: combination with isoenzymatic characters for determination of linkage groups. Parasitol Res 81:32–37

    Article  PubMed  CAS  Google Scholar 

  6. Frenkel JK, Ambroise-Thomas P (1997) Genomic drift of Toxoplasma gondii. Parasitol Res 23:1249–1254

    Google Scholar 

  7. Ancelle T, Goulet V, Tirard-Fleury V et al (1996) La toxoplasmose chez la femme enceinte en France en 1995. BEH 51:227–229

    Google Scholar 

  8. Aspock H, Pollak A (1992) Prevention of prenatal toxoplasmosis by serological screening of pregnant women in Austria. Scand J Infect Dis (Suppl) 84:32–37

    CAS  Google Scholar 

  9. Bourget P, Lesne-Hulin A, Forestier F et al (1996) Prévention de la Toxoplasmose congénitale par la spiramycine: valeur et limites des concentrations dans le liquide amniotique. Therapie 51:685–687

    PubMed  CAS  Google Scholar 

  10. Daffos F, Forestier F, Capella-Pavlovski M et al (1988) Prenatal management of 746 pregnancies at risk for congenital toxoplasmosis N Engl J Med 318:271–275

    Article  PubMed  CAS  Google Scholar 

  11. Desmonts G, Daffos F, Forestier F et al (1985) Prenatal diagnosis of congenital toxoplamosis. Lancet 1:500–504

    Article  PubMed  CAS  Google Scholar 

  12. Petithory JC, Ambroise-Thomas P, de Loye J et al (1996) Sero-diagnostic de la toxoplasmose. Etude comparative multicentrique d’une gamme étalon par les différents tests actuels et avec expression des résultats en Unités Internationales. Bull OMS 74:291–298

    CAS  Google Scholar 

  13. Pelloux H, Brun E, Vernet G et al (1998) Determination of anti-Toxoplasma gondii immunoglobulin G avidity: application to the Vidas system. Diagn Microbiol Infect Dis 32:69–73

    Article  PubMed  CAS  Google Scholar 

  14. Fricker-Hidalgo H, Pelloux H, Muet F et al (1997) Prenatal diagnosis of congenital toxoplasmosis: comparative value of fetal blood and amniotic fluid using serological technics. Pren Diagn 17:831–885

    Article  CAS  Google Scholar 

  15. Guy EC, Pelloux H, Lappalainen M et al (1996) Interlaboratory comparison of Polymerase Chain Reaction for the detection of Toxoplasma gondii DNA added to samples of amniotic fluids. Eur J Clin Microbiol Infect Dis 15:36–839

    Article  Google Scholar 

  16. Pelloux H, Weiss J, Simon J et al (1996) A new set of primers for the detection of Toxoplasma gondii in amniotic fluid using polymerase chain reaction. FEMS Microbiol Lett 138:1–15

    Article  Google Scholar 

  17. Pelloux H, Guy E, Angelici MC et al (1998) A second european collaborative study on polymerase chain reaction for Toxoplasma gondii, involving 15 teams. FEMS Microbiol Lett 165:231–237

    Article  PubMed  CAS  Google Scholar 

  18. Contreras M, Schenone H, Salinas P et al (1996) Seroepidemiology of human toxoplasmosis in Chile. Rev Inst Med Trop Sao Paulo 38:431–435

    Article  PubMed  CAS  Google Scholar 

  19. Jenum PA, Stray-Pedersen B, Melby KK et al (1998) Incidence of Toxoplasma gondii infection in 35,940 pregnant women in Norway and pregnancy outcome for infected women. J Clin Microbiol 36:2900–2906

    PubMed  CAS  Google Scholar 

  20. Fricker-Hidalgo H, Pelloux H, Bost M et al (1996) Toxoplasmose congénitale : apport du suivi biologique post-natal. Presse Méd 25:1868–1872

    PubMed  CAS  Google Scholar 

  21. McAuley J, Boyer KM, Patel D et al (1994) Early and longitudinal evaluation of treated infants and children and untreated historical patients with congenital toxoplamosis:the Chicago collaborative treatment trial. Clin Infect Dis 18:38–72

    Article  PubMed  CAS  Google Scholar 

  22. Foulon W, Naessens A, Lauwers S et al (1988) Impact of primary prevention on the incidence of toxoplasmosis during pregnancy. Obst Gynecol 72:363–366

    CAS  Google Scholar 

  23. Foulon W (1992) Congenital toxoplasmosis: is screening desirable? Scand J Infect Dis (Suppl) 84:11-17

    CAS  Google Scholar 

  24. Foulon W, Naessens A, Derde MP (1994) Evaluation of the possibilities for preventing congenital toxoplasmosis. Am J Perinatol 11:57–62

    Article  PubMed  CAS  Google Scholar 

  25. Guerina NG, Hsy HW, Meissner C et al (1994) Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. N Engl J Med 330:1858–1863

    Article  PubMed  CAS  Google Scholar 

  26. Hohlfeld P, Biedermann K, Extermann P et al (1995) Toxoplasmose pendant la grossesse : prévention, diagnostic prénatal et traitement. Schweiz Med Wochenschr (Suppl), 65:62S–69S

    CAS  Google Scholar 

  27. Holliman RE (1995) Congenital toxoplasmosis: prevention, screening and treatment. J Hosp Infect 30:179–190

    Article  PubMed  Google Scholar 

  28. Lappalainen M, Sintonen H, Koskiniemi M et al (1995) Cost-benefit analysis of screening for toxoplasmosis during pregnancy. Scand J Infect Dis 27:265–272

    Article  PubMed  CAS  Google Scholar 

  29. Szenasi Z, Ozsvar Z, Nagy E et al (1997) Prevention of congenital toxoplasmosis in Szeged, Hungary. Int J Epidemiol 26:428–435

    Article  PubMed  CAS  Google Scholar 

  30. Wallon M, Mallaret MR, Mojon M et al (1994) Toxoplasmose congénitale, évaluation de la prévention. Presse Méd 23:1467–1470

    PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer-Verlag France

About this paper

Cite this paper

Ambroise-Thomas, P., Petersen, E. (2000). Congenital toxoplasmosis: past, present and future. In: Ambroise-Thomas, P., Petersen, P.E. (eds) Congenital toxoplasmosis. Springer, Paris. https://doi.org/10.1007/978-2-8178-0847-5_1

Download citation

  • DOI: https://doi.org/10.1007/978-2-8178-0847-5_1

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-287-59664-3

  • Online ISBN: 978-2-8178-0847-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics